The federal contract Indefinite Delivery Vehicle (IDV) award is a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc. The contract has a total ceiling value of $290,000,000 and a period of performance through March 31, 2030.
The focus of this IDV contract is the delivery of Progenics' radiopharmaceutical product PYLARIFY, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The contract allows various VA medical facilities and the Defense Health Agency to issue task orders for the procurement of PYLARIFY and other specialized radiopharmaceuticals and nuclear medicine supplies. The IDV includes multiple Blanket Purchase Agreements (BPAs) with the VA and Defense Health Agency, ranging from $250,000 to $6.5 million in total potential value. These contract vehicles facilitate the efficient acquisition of critical diagnostic imaging agents by federal healthcare providers, primarily supporting oncology services and nuclear medicine programs across the VA and military treatment facilities.
Generated 3/30/25, 12:47 AM